Chen Wei-Min, Erdos Michael R, Jackson Anne U, Saxena Richa, Sanna Serena, Silver Kristi D, Timpson Nicholas J, Hansen Torben, Orrù Marco, Grazia Piras Maria, Bonnycastle Lori L, Willer Cristen J, Lyssenko Valeriya, Shen Haiqing, Kuusisto Johanna, Ebrahim Shah, Sestu Natascia, Duren William L, Spada Maria Cristina, Stringham Heather M, Scott Laura J, Olla Nazario, Swift Amy J, Najjar Samer, Mitchell Braxton D, Lawlor Debbie A, Smith George Davey, Ben-Shlomo Yoav, Andersen Gitte, Borch-Johnsen Knut, Jørgensen Torben, Saramies Jouko, Valle Timo T, Buchanan Thomas A, Shuldiner Alan R, Lakatta Edward, Bergman Richard N, Uda Manuela, Tuomilehto Jaakko, Pedersen Oluf, Cao Antonio, Groop Leif, Mohlke Karen L, Laakso Markku, Schlessinger David, Collins Francis S, Altshuler David, Abecasis Gonçalo R, Boehnke Michael, Scuteri Angelo, Watanabe Richard M
Department of Public Health Sciences, University of Virginia, Charlottesville, Virginia, USA.
J Clin Invest. 2008 Jul;118(7):2620-8. doi: 10.1172/JCI34566.
Identifying the genetic variants that regulate fasting glucose concentrations may further our understanding of the pathogenesis of diabetes. We therefore investigated the association of fasting glucose levels with SNPs in 2 genome-wide scans including a total of 5,088 nondiabetic individuals from Finland and Sardinia. We found a significant association between the SNP rs563694 and fasting glucose concentrations (P = 3.5 x 10(-7)). This association was further investigated in an additional 18,436 nondiabetic individuals of mixed European descent from 7 different studies. The combined P value for association in these follow-up samples was 6.9 x 10(-26), and combining results from all studies resulted in an overall P value for association of 6.4 x 10(-33). Across these studies, fasting glucose concentrations increased 0.01-0.16 mM with each copy of the major allele, accounting for approximately 1% of the total variation in fasting glucose. The rs563694 SNP is located between the genes glucose-6-phosphatase catalytic subunit 2 (G6PC2) and ATP-binding cassette, subfamily B (MDR/TAP), member 11 (ABCB11). Our results in combination with data reported in the literature suggest that G6PC2, a glucose-6-phosphatase almost exclusively expressed in pancreatic islet cells, may underlie variation in fasting glucose, though it is possible that ABCB11, which is expressed primarily in liver, may also contribute to such variation.
识别调控空腹血糖浓度的基因变异可能会增进我们对糖尿病发病机制的理解。因此,我们在两项全基因组扫描中研究了空腹血糖水平与单核苷酸多态性(SNP)的关联,这两项扫描共纳入了来自芬兰和撒丁岛的5088名非糖尿病个体。我们发现SNP rs563694与空腹血糖浓度之间存在显著关联(P = 3.5 x 10^(-7))。在另外18436名来自7项不同研究的欧洲混血非糖尿病个体中对这种关联进行了进一步研究。这些后续样本中关联的合并P值为6.9 x 10^(-26),将所有研究的结果合并后得出的总体关联P值为6.4 x 10^(-33)。在这些研究中,每增加一个主要等位基因拷贝,空腹血糖浓度就会升高0.01 - 0.16 mM,约占空腹血糖总变异的1%。SNP rs563694位于葡萄糖-6-磷酸酶催化亚基2(G6PC2)基因和ATP结合盒亚家族B(多药耐药/抗原加工相关转运蛋白)成员11(ABCB11)基因之间。我们的研究结果与文献报道的数据表明,G6PC2(一种几乎仅在胰岛细胞中表达的葡萄糖-6-磷酸酶)可能是空腹血糖变异的基础,不过主要在肝脏中表达的ABCB11也有可能导致这种变异。